Aditya Basu

EN | BioFlux - The Brief (English)

News EN ↓ 27 episoder

NexTechie BioFlux: Tracking the Tech That Heals, Evolves, and Informs. Biotechnology and health innovation are transforming the way we live, heal, and understand the human body. NexTechie BioFlux – The Brief delivers clarity, speed, and authority in a rapid 3‑minute audio overview designed for professionals, innovators, and decision‑makers who need to stay ahead of the biotech frontier. Every episode distills the most important breakthroughs, platforms, and strategies into a concise briefing that respects your time while expanding your perspective. BioFlux is more than just a podcast—it’s a st...

Husk å besøke podkastens nettsted og støtte skaperen: vip.nextechie.in

Forfatter

Aditya Basu

Kategori

News

Podkastens nettsted

vip.nextechie.in

Siste episode

7. okt 2026

Hvor kan du lytte?

Podkaster i appen Replaio Radio Kommer snart

Podkaster kommer snart til appen. Installer nå, og bli den første som ser en helt ny tilnærming til podkaster

Installer gratis Android nesten 10 mill. nedlastinger · 4,8 i vurdering iOS snart

Episoder

NexTechie BioFLux - The Brief: Ubiquitous AI Clinician Transforming Diagnostics, Drug Discovery, and Delivery 21.11.2025 2:52

In this edition, we dissect the explosive impact of Artificial Intelligence across the entire healthcare continuum. We begin with our central theme, exploring how AI is making a monumental diagnostic leap, evolving everyday tools like the stethoscope into powerful real-time analyzers and revolutionizing how we interpret complex imaging for conditions like stroke and heart disease. Subscribe to the...

NexTechie BioFlux - The Brief: Asset-Centric Biotech Funding, Rise of AI in Diagnostics and Surgery, FDA's New Path for Bespoke Therapies 15.11.2025 2:19

Welcome to NexTechie BioFlux - The Brief. Your smart dive into tech that heals, evolves, and informs. In this edition, we dissect Medicxi's landmark €500M fund and what its 'asset-centric' strategy means for the entire innovation pipeline. We then pivot to groundbreaking developments across the sectors, from generative AI platforms that outperform doctors in complex diagnostics to next-generation...